Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
130.1 USD | -0.82% | +2.51% | +19.35% |
Apr. 29 | Merck Reports Positive Data for Investigational 21-Valent Pneumococcal Vaccine | MT |
Apr. 29 | Blackstone beats Concord with $1.6 bln bid for Hipgnosis Songs | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.35% | 332B | |
+26.47% | 661B | |
+26.74% | 566B | |
-6.33% | 352B | |
+4.23% | 283B | |
+13.43% | 231B | |
+4.71% | 200B | |
-9.53% | 195B | |
-4.04% | 145B | |
-10.94% | 144B |
- Stock Market
- Equities
- MRK Stock
- News Merck & Co., Inc.
- UBS Adjusts Merck & Company Price Target to $135 From $122, Maintains Buy Rating